1 – 10 of 16
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Cerebrospinal fluid levels of neurogranin in Parkinsonian disorders
(
- Contribution to journal › Article
- 2019
-
Mark
Mapping of apparent susceptibility yields promising diagnostic separation of progressive supranuclear palsy from other causes of parkinsonism
(
- Contribution to journal › Article
- 2018
-
Mark
Alteration of putaminal fractional anisotropy in Parkinson’s disease : a longitudinal diffusion kurtosis imaging study
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid concentrations of inflammatory markers in Parkinson’s disease and atypical parkinsonian disorders
(
- Contribution to journal › Article
- 2016
-
Mark
Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease.
2016) In Movement Disorders(
- Contribution to journal › Article
-
Mark
Alterations of diffusion kurtosis and neurite density measures in deep grey matter and white matter in Parkinson's disease
(
- Contribution to journal › Article
- 2015
-
Mark
The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer's but Not Parkinson's Disease or Dementia with Lewy Bodies.
(
- Contribution to journal › Article
-
Mark
CSF biomarkers and clinical progression of Parkinson disease.
(
- Contribution to journal › Article
-
Mark
Disease-specific structural changes in thalamus and dentatorubrothalamic tract in progressive supranuclear palsy.
(
- Contribution to journal › Article
- 2014
-
Mark
Low Levels of Soluble NG2 in Cerebrospinal Fluid from Patients with Dementia with Lewy Bodies.
2014) In Journal of Alzheimer's Disease(
- Contribution to journal › Article